Abstract
In a dose-response study of prazosin in 24 patients with Raynaud's phenomenon, the clinical effectiveness and side effects of 3, 6, and 12 mg prazosin administered daily were compared. Diary analysis and measurement of finger skin blood flow and temperature before, during, and after cold challenge showed no major differences among these three dose regimens. Standing systolic blood pressure decreased significantly during the 12-mg period in comparison with the 6-mg (P less than .05) and with the 3-mg period (P less than .02), whereas heart rate increased in the 6-mg and 3-mg periods (P less than .05). In the higher dosage ranges, spontaneous mentioned side effects were noticed most often, which was in accordance with the results of a checklist analysis on adverse effects. Three patients withdrew from the study because of complaints that might be due to orthostatic hypotension. Most patients that wanted to continue prazosin after this study (n = 13) did so on a 3-mg basis (n = 10). Because prazosin 3 mg daily is more effective in treating of Raynaud's phenomenon than is placebo, the study shows that in a dosage of 3 mg daily, the best balance between clinical effectiveness and side effects is obtained.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
